Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 22, Issue 6 , Pages 1025-1041 , December 2008

Misoprostol for the prevention and treatment of postpartum haemorrhage

  • G. Justus Hofmeyr, MRCOG (Prof)

      Affiliations

    • Corresponding Author InformationCorresponding author. Dept of Obstetrics and Gynaecology, East London Hospital Complex, PB X9047, East London 5201, South Africa, Tel.: +27 0 43 709 2483; Fax: +866929822.

References 

  1. Potts M, Hemmerling A. The worldwide burden of postpartum haemorrhage: policy development where inaction is lethal. Int J Gynaecol Obstet. 2006 Nov;94(Suppl. 2):S116–S121
  2. Prendiville WJ, Elbourne D, McDonald S. Active versus expectant management in the third stage of labour. Cochrane Database Syst Rev. 2000;(Issue 3):Art. NoCD000007
  3. Cotter A, NessTolosa J. Prophylactic oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2001;(Issue 4):Art. NoCD001808
  4. Liabsuetrakul T, Choobun T, Peeyananjarassri K, et al. Prophylactic use of ergot alkaloids in the third stage of labour. Cochrane Database Syst Rev. 2007;(Issue 2):Art. NoCD005456
  5. McDonald S, Abbott JM, Higgins SP. Prophylactic ergometrine-oxytocin versus oxytocin for the third stage of labour. Cochrane Database Syst Rev. 2004;(Issue 1):Art. NoCD000201
  6. Ronsmans C, Graham WJ. Maternal mortality: who, when, where, and why. Lancet. 2006;368:1189–1200
  7. Fawcus S, Mbizvo MT, Lindmark G, et al. Maternal mortality study group. Community based investigation of causes of maternal mortality in rural and urban Zimbabwe. Cent Afr J Med. 1995;41:105–113
  8. Ramanathan G, Arulkumaran S. Postpartum hemorrhage. J Obstet Gynaecol Can. 2006 Nov;28(11):967–973
  9. McDonald S. Management of the third stage of labor. J Midwifery Womens Health. 2007;52(3):254–261
  10. Norman JE, Thong KJ, Baird DT. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone. Lancet. 1991;338:1233–1236
  11. Mariani Neto C, Delbin AL, do Val Junior R. Tocographic pattern induced by misoprostol. Rev Paul Med. 1988;106:205–208
  12. el-Refaey H, Templeton A. Early induction of abortion by a combination of oral mifepristone and misoprostol administered by the vaginal route. Contraception. 1994;49:111–114
  13. Hofmeyr GJ, Gulmezoglu AM, Alfirevic Z. Misoprostol for induction of labour: a systematic review. BJOG. 1999;106:798–803
  14. Hofmeyr GJ. Misoprostol in obstetrics and gynaecology–unregistered, dangerous and essential. S Afr Med J. 1998;88:535–536
  15. Tang OS, Gemzell-Danielsson K, Ho PC. Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects. Int J Gynaecol Obstet. 2007 Dec;99(Suppl. 2):S160–S167
  16. Moore ML. Misoprostol-is more research needed?. J Perinat Educ. 2002 Summer;11(3):43–47
  17. Hofmeyr GJ, Walraven G, Gulmezoglu AM, et al. Misoprostol to treat postpartum haemorrhage: a systematic review. BJOG. 2005 May;112(5):547–553
  18. Zieman M, Fong SK, Benowitz NL, et al. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90:88–91
  19. Danielsson KG, Marions L, Rodriguez A, et al. Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynecol. 1999;93:275–280
  20. Tang OS, Schweer H, Seyberth HW, et al. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod. 2002;17:332–336
  21. Abdel-Aleem H, Villar J, Gülmezoglu AM, et al. The pharmacokinetics of the prostaglandin E1 analogue misoprostol in plasma and colostrum after postpartum oral administration. Eur J Obstet Gynecol Reprod Biol. 2003;108(1):25–28
  22. Khan R-U, El-Refaey H. Pharmacokinetics and adverse-effect profile of rectally administered misoprostol in the third stage of labor. Obstet Gynecol. 2003;101:968–974
  23. Andolina KL, Tolosa JE, Monzo JM, et al. Oral misoprostol is rapidly absorbed in postpartum women at term. J Matern Fetal Neonatal Med. 2003;14:229–232
  24. Chong YS, Chua S, El-Refaey H, et al. Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine. Br J Obstet Gynaecol. 2001;108:41–47
  25. Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effects of misoprostol on uterine contractility following different routes of administration. Human Reproduction. 2004;19:81–84
  26. Shetty A, Danielian P, Templeton A. Sublingual misoprostol for the induction of labour at term. Am J Obstet Gynecol. 2002;186:72–76
  27. Pi P, Zhu F. Clinical observation of misoprostol on induction in late pregnancy. (Chinese) Bull of Hunan Med Univ. 1999;24:195–197
  28. Saxena P, Sarda N, Salhan S, et al. A randomised comparison between sublingual, oral and vaginal route of misoprostol for pre-abortion cervical ripening in first-trimester pregnancy termination under local anaesthesia. Aust N Z J Obstet Gynaecol. 2008 Feb;48(1):101–106
  29. Bamigboye A, Merrell DA, Mitchel R, et al. Randomised comparison of misoprostol with syntometrine for management of third stage of labor. Acta Obstet Gynecol Scand. 1998;77:178–182
  30. Hofmeyr GJ, Nikodem VC, de Jager M, et al. A randomised placebo controlled trial of oral misoprostol in the third stage of labour. Br J Obstet Gynaecol. 1998;105:971–975
  31. Gülmezoglu AM, Villar J, Ngoc NN, et al. for the WHO Collaborative Group To Evaluate Misoprostol in the Management of the Third Stage of Labour The WHO multicentre double-blind randomized controlled trial to evaluate the use of misoprostol in the management of the third stage of labour. Lancet. 2001;358:689–695
  32. Hoj L, Cardosa P, Nielsen BB, et al. Effect of sublingual misoprostol on severe postpartum haemorrhage in aprimary health centre in Guinea-Bissau: randomized double blind clinical trial. BMJ. 2005;331:723
  33. Morgan SC. Inadequate reporting of safety issues from clinical trials in academic journals. BMJ. October 2005;14:
  34. Sloan NL, Winikoff B, Blum J. Questions for authors regarding the effect of sublingual misoprostol on postpartum haemorrhage. Rapid Response to Hoj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Peter Aaby P. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind control trial. BMJ. 2005;331:723
  35. Derman RJ, Kodkany BS, Goudar SS, et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomized controlled trial. Lancet. 2006;368:1248–1253
  36. Hofmeyr GJ, Nikodem VC, de Jager M, et al. Side-effects of oral misoprostol in the third stage of labour - a randomised placebo-controlled trial. S Afr Med J. 1998;91:432–435
  37. Lokugamage AU, Sullivan KR, Niculescu I, et al. A randomized study comparing rectally administered misoprostol versus syntometrine combined with an oxytocin infusion for the cessation of primary post partum hemorrhage. Acta Obstet Gynecol Scand. 2001;80:835–839
  38. Cook CM, Spurrett B, Murray H. A randomized clinical trial comparing oral misoprostol with synthetic oxytocin or syntometrine in the third stage of labour. Aust N Z J Obstet Gynaecol. 1999;39:414–419
  39. Walraven G, Blum J, Dampha Y, et al. Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial. BJOG. 2005;112:1277–1283
  40. Hofmeyr GJ, Ferreira S, Nikodem VC, et al. Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]. BMC Pregnancy Childbirth. 2004;4:16
  41. Baskett TF, Persad VL, Clough HJ, et al. Misoprostol versus oxytocin for the reduction of postpartum blood loss. Int J Gynaecol Obstet. 2007;97:2–5
  42. Walley RL, Wilson JB, Crane JM, et al. A double-blind placebo controlled randomised trial of misoprostol and oxytocin in the management of the third stage of labour. BJOG. 2000;107:1111–1115
  43. Kundodyiwa TW, Majoko F, Rusakaniko S. Misoprostol versus oxytocin in the third stage of labor. Int J Gynaecol Obstet. 2001;75:235–241
  44. Hofmeyr GJ, Gulmezoglu AM. Misoprostol in the third stage of labour and maternal mortality: a review. Rapid Response to Hoj L, Cardoso P, Nielsen BB, Hvidman L, Nielsen J, Peter Aaby P. Effect of sublingual misoprostol on severe postpartum heamorrhage in aprimary health centre in Guinea-Bissau: randomised double blind control trial. BMJ. 2005;331:723;BMJ, 2006
  45. Chong YS, Chua S, Arulkumaran S. Severe hyperthermia following oral misoprostol in the immediate postpartum period. Obstet Gynecol. 1997 Oct;90(4):703–704
  46. Winikoff B, Barrera G, Leon W, et al. A case review of high fevers occurring after treatment administration for primary postpartum hemorrhage. Oral Communication, XVIII FIGO World Congress of Gynecology & Obstetrics, November 2006, Kuala Lumpur, Malaysia.
  47. Epstein AE, Hallstrom AP, Rogers WJ, et al. Mortality following ventricular arrhythmia suppression by encainide, flecainide, and moricizine after myocardial infarction. The original design concept of the cardiac arrhythmia suppression trial (CAST). JAMA. 1993;270:2451–2455
  48. Bucher HC, Guyatt GH, Griffith LE, et al. The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials. J Clin Epidemiol. 1997;50:683–691
  49. Song F, Altman DG, Glenny AM, et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ. 2003;326:472
  50. Htay TT. Making pregnancy safer in Myanmar: introducing misoprostol to prevent post-partum haemorrhage as part of active management of the third stage of labour. Reprod Health Matters. 2007 Nov;15(30):214–215
  51. Jadesimi A, Okonofua FE. Tackling the unacceptable: Nigeria approves misoprostol for postpartum haemorrhage. J Fam Plann Reprod Health Care. 2006 Oct;32(4):213–214
  52. Geller SE, Adams MG, Kelly PJ, et al. Postpartum hemorrhage in resource-poor settings. Int J Gynaecol Obstet. 2006 Mar;92(3):202–211
  53. Matsuo K, Scanlon JT, Atlas RO, et al. Staircase sign: a newly described uterine contraction pattern seen in rupture of unscarred gravid uterus. J Obstet Gynaecol Res. 2008 Feb;34(1):100–104
  54. Wing DA, Lovett K, Paul RH. Disruption of prior uterine incision following misoprostol for labour induction in women with previous cesarean delivery. Am J Obstet Gynecol. 1998;91(5):828–830
  55. Rogers MS, Yuen PM, Wong S. Avoiding manual removal of placenta: evaluation of intra-umbilical injection of uterotonics using the Pipingas technique for management of adherent placenta. Acta Obstet Gynecol Scand. 2007;86(1):48–54
  56. Alfirevic Z, Blum J, Walraven G, et al. Prevention of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet. 2007 Dec;99(Suppl. 2):S198–S201
  57. Blum J, Alfirevic Z, Walraven G, et al. Treatment of postpartum hemorrhage with misoprostol. Int J Gynaecol Obstet. 2007 Dec;99(Suppl. 2):S202–S205

PII: S1521-6934(08)00101-6

doi: 10.1016/j.bpobgyn.2008.08.005

Best Practice & Research Clinical Obstetrics & Gynaecology
Volume 22, Issue 6 , Pages 1025-1041 , December 2008

Article Tools

* Image Usage & Resolution